Bradley R Javorsky1, Ty B Carroll2, Nicholas A Tritos3, Roberto Salvatori4, Anthony P Heaney5, Maria Fleseriu6, Beverly M K Biller3, James W Findling2. 1. Endocrinology Center and Clinics, Froedtert and Medical College of Wisconsin, W129 N7055 Northfield Drive, Building A, Suite 203 Menomonee Falls, Milwaukee, WI, 53051, USA. bradley.javorsky@froedtert.com. 2. Endocrinology Center and Clinics, Froedtert and Medical College of Wisconsin, W129 N7055 Northfield Drive, Building A, Suite 203 Menomonee Falls, Milwaukee, WI, 53051, USA. 3. Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA. 4. Division of Endocrinology, Diabetes and Metabolism and Pituitary Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 5. David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. 6. Departments of Medicine and Neurological Surgery, Northwest Pituitary Center, Oregon Health & Science University, Portland, OR, USA.
Abstract
PURPOSE: The aim of this study is to demonstrate the importance of considering Cushing's syndrome (CS) as a potential etiology for weight gain and metabolic complications in patients undergoing bariatric surgery (BS). DESIGN AND METHODS: This is a retrospective chart review case series of patients (n = 16) with CS from five tertiary care centers in the USA who had BS. RESULTS: Median age at BS surgery was 35.5 years (median 2.5 years between BS and CS surgery). CS was not identified in 12 patients prior to BS. Four patients had CS surgery prior to BS, without recognition of recurrent or persistent CS until after BS. Median body mass index (BMI) values before BS, nadir after BS, prior to surgery for CS, and after surgery for CS were 47, 31, 38, and 35 kg/m(2), respectively. Prior to BS, 55 % of patients had hypertension and 55 % had diabetes mellitus. Only 17 % had resolution of hypertension or diabetes mellitus after BS. CONCLUSION: CS may be under-recognized in patients undergoing BS. Testing for CS should be performed prior to BS in patients with features of CS and in post-operative BS patients with persistent hypertension, diabetes mellitus, or excessive weight regain. Studies should be conducted to determine the role of prospective testing for CS in subjects considering BS.
PURPOSE: The aim of this study is to demonstrate the importance of considering Cushing's syndrome (CS) as a potential etiology for weight gain and metabolic complications in patients undergoing bariatric surgery (BS). DESIGN AND METHODS: This is a retrospective chart review case series of patients (n = 16) with CS from five tertiary care centers in the USA who had BS. RESULTS: Median age at BS surgery was 35.5 years (median 2.5 years between BS and CS surgery). CS was not identified in 12 patients prior to BS. Four patients had CS surgery prior to BS, without recognition of recurrent or persistent CS until after BS. Median body mass index (BMI) values before BS, nadir after BS, prior to surgery for CS, and after surgery for CS were 47, 31, 38, and 35 kg/m(2), respectively. Prior to BS, 55 % of patients had hypertension and 55 % had diabetes mellitus. Only 17 % had resolution of hypertension or diabetes mellitus after BS. CONCLUSION: CS may be under-recognized in patients undergoing BS. Testing for CS should be performed prior to BS in patients with features of CS and in post-operative BS patients with persistent hypertension, diabetes mellitus, or excessive weight regain. Studies should be conducted to determine the role of prospective testing for CS in subjects considering BS.
Entities:
Keywords:
Causes of surgical failure; Cushing’s syndrome; Hormonal causes of weight gain; Hypercortisolism; Preoperative screening for bariatric surgery; Weight regain after surgery
Authors: Rosane Ness-Abramof; Dan Nabriski; Caroline M Apovian; Mark Niven; Eliahu Weiss; Menachem S Shapiro; Louis Shenkman Journal: Obes Res Date: 2002-12
Authors: Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Elena Valassi; Alicia Santos; Maria Yaneva; Miklós Tóth; Christian J Strasburger; Philippe Chanson; John A H Wass; Olivier Chabre; Marija Pfeifer; Richard A Feelders; Stylianos Tsagarakis; Peter J Trainer; Holger Franz; Kathrin Zopf; Sabina Zacharieva; Steven W J Lamberts; Antoine Tabarin; Susan M Webb Journal: Eur J Endocrinol Date: 2011-06-29 Impact factor: 6.664
Authors: Daniéla Oliveira Magro; Bruno Geloneze; Regis Delfini; Bruna Contini Pareja; Francisco Callejas; José Carlos Pareja Journal: Obes Surg Date: 2008-04-08 Impact factor: 4.129
Authors: Giuseppe Reimondo; Anna Pia; Barbara Allasino; Francesco Tassone; Silvia Bovio; Giorgio Borretta; Alberto Angeli; Massimo Terzolo Journal: Clin Endocrinol (Oxf) Date: 2007-06-04 Impact factor: 3.478
Authors: S Petersenn; J Newell-Price; J W Findling; F Gu; M Maldonado; K Sen; L R Salgado; A Colao; B M K Biller Journal: Clin Endocrinol (Oxf) Date: 2013-07-15 Impact factor: 3.478
Authors: J Aberle; C Schulze Zur Wiesch; J Flitsch; J Veigel; G Schön; R Jung; F Reining; A Lautenbach; R Rotermund; N Riedel Journal: J Endocrinol Invest Date: 2018-03-17 Impact factor: 4.256
Authors: Leah T Braun; Frederick Vogel; Stephanie Zopp; Thomas Marchant Seiter; German Rubinstein; Christina M Berr; Heike Künzel; Felix Beuschlein; Martin Reincke Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134